Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Dongqing Yan
Affiliation
Inner Mongolia University
ORCID
Career Start Year
2010
Papers
24
H Index
11
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37265641
Genomic insights into genetic diversity and local adaptation of a dominant desert steppe feather grass, <i>Stipa breviflora</i> Griseb.
Front Plant Sci
2023
34780648
MS4A3 promotes differentiation in chronic myeloid leukemia by enhancing common β-chain cytokine receptor endocytosis.
Blood
2022
36536477
Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism.
Clin Transl Med
2022
33412552
Femoral Heads from Total Hip Arthroplasty as a Source of Adult Hematopoietic Cells.
Acta Haematol
2021
34027418
SIRT5 IS A DRUGGABLE METABOLIC VULNERABILITY IN ACUTE MYELOID LEUKEMIA.
Blood Cancer Discov
2021
32409689
Dasatinib overcomes stroma-based resistance to the FLT3 inhibitor quizartinib using multiple mechanisms.
Leukemia
2020
31980730
Coordinated inhibition of nuclear export and Bcr-Abl1 selectively targets chronic myeloid leukemia stem cells.
Leukemia
2020
33351838
De novo assembly, annotation, marker discovery, and genetic diversity of the Stipa breviflora Griseb. (Poaceae) response to grazing.
PLoS One
2020
30563936
Nuclear-Cytoplasmic Transport Is a Therapeutic Target in Myelofibrosis.
Clin Cancer Res
2019
31697804
JAK2 ex13InDel drives oncogenic transformation and is associated with chronic eosinophilic leukemia and polycythemia vera.
Blood
2019
31648319
The transcriptome of CMML monocytes is highly inflammatory and reflects leukemia-specific and age-related alterations.
Blood Adv
2019
31543464
Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 Mutants.
Cancer Cell
2019
31540978
ddeeper Than Deep: Can ddPCR Predict Successful Imatinib Cessation?
Clin Cancer Res
2019
28025836
STAT3 mutations are not sufficient to induce large granular lymphocytic leukaemia in mice.
Br J Haematol
2018
29588547
Ongoing clonal evolution in chronic myelomonocytic leukemia on hypomethylating agents: a computational perspective.
Leukemia
2018
29749399
Autocrine Tnf signaling favors malignant cells in myelofibrosis in a Tnfr2-dependent fashion.
Leukemia
2018
27480386
Rapid conversion of chronic myeloid leukemia to chronic myelomonocytic leukemia in a patient on imatinib therapy.
Leukemia
2016
26648538
Age-related mutations and chronic myelomonocytic leukemia.
Leukemia
2016
26582647
Extreme mutational selectivity of axitinib limits its potential use as a targeted therapeutic for BCR-ABL1-positive leukemia.
Leukemia
2016
26044284
Deletion of Stat3 enhances myeloid cell expansion and increases the severity of myeloproliferative neoplasms in Jak2V617F knock-in mice.
Leukemia
2015
22144185
Critical requirement for Stat5 in a mouse model of polycythemia vera.
Blood
2012
22837531
Tyrosine 201 is required for constitutive activation of JAK2V617F and efficient induction of myeloproliferative disease in mice.
Blood
2012
21362419
Differential biological activity of disease-associated JAK2 mutants.
FEBS Lett
2011
20197548
Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera-like disease.
Blood
2010
1 - 24 of 24
Column Actions
Search
Recommended Authors
Haijiao Zhang
Oregon Health & Science University, Knight Cancer Institute
Career Start Year
2017
Number of shared co-authors
13
Zhijie Wu
and Blood Institute, National Institutes of Health
Career Start Year
2013
Number of shared co-authors
0
Fiorella Schischlik
National Cancer Institute, National Institutes of Health
Career Start Year
2013
Number of shared co-authors
0
Bartlomiej Przychodzen
Vanda Pharmaceuticals Inc.
Career Start Year
2010
Number of shared co-authors
0
Lina Benajiba
Universite de Paris, Inserm CIC 1427
Career Start Year
2009
Number of shared co-authors
0
Julia E Maxson
Knight Cancer Institute, Oregon Health & Science University
Career Start Year
2009
Number of shared co-authors
15
Anagha Deshpande
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year
2009
Number of shared co-authors
0
Paulo Vidal Campregher
Hospital Israelita Albert Einstein
Career Start Year
2007
Number of shared co-authors
0
Christopher Y Park
NYU Robert I. Grossman School of Medicine
Career Start Year
2006
Number of shared co-authors
0
Fumio Nakahara
Graduate School of Medicine, The University of Tokyo
Career Start Year
2004
Number of shared co-authors
0
Anna L Brown
Adelaide Medical School, University of Adelaide
Career Start Year
2003
Number of shared co-authors
3
Thomas Ernst
Universitatsklinikum Jena
Career Start Year
2002
Number of shared co-authors
3
Fei Yang
Oregon Health & Science University
Career Start Year
2002
Number of shared co-authors
11
Stephen T Oh
Washington University School of Medicine
Career Start Year
2001
Number of shared co-authors
13
Jeffery M Klco
St. Jude Children's Research Hospital
Career Start Year
2000
Number of shared co-authors
1
Elie Traer
Oregon Health & Science University
Career Start Year
1998
Number of shared co-authors
14
Ravindra Majeti
Stanford University School of Medicine
Career Start Year
1998
Number of shared co-authors
4
Angela G Fleischman
University of California Irvine
Career Start Year
1998
Number of shared co-authors
9
Stephanie Halene
Smilow Cancer Center, Yale University School of Medicine
Career Start Year
1997
Number of shared co-authors
1
Brian J P Huntly
University of Cambridge
Career Start Year
1996
Number of shared co-authors
2
Robert Kralovics
Medical University of Vienna
Career Start Year
1995
Number of shared co-authors
2
Yongjin Li
Mayo Clinic
Career Start Year
1995
Number of shared co-authors
1
Lucy A Godley
The University of Chicago
Career Start Year
1994
Number of shared co-authors
4
Matthew J Walter
Washington University School of Medicine in St. Louis
Career Start Year
1994
Number of shared co-authors
1
Seishi Ogawa
Kyoto University
Career Start Year
1993
Number of shared co-authors
3
Michael Heuser
Hannover Medical School
Career Start Year
1993
Number of shared co-authors
2
Timothy A Graubert
Massachusetts General Hospital
Career Start Year
1993
Number of shared co-authors
3
Michael W Becker
James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester
Career Start Year
1992
Number of shared co-authors
2
Marc M Loriaux
Knight Cancer Institute, Oregon Health & Science University
Career Start Year
1991
Number of shared co-authors
14
Toshio Kitamura
The University of Tokyo.
Career Start Year
1984
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Michael W Deininger
University of Utah Huntsman Cancer Institute
Co-authored papers
15
Anthony D Pomicter
Huntsman Cancer Institute, University of Utah
Co-authored papers
15
Thomas O'Hare
Huntsman Cancer Institute, University of Utah
Co-authored papers
13
Phillip M Clair
Huntsman Cancer Institute, The University of Utah
Co-authored papers
8
Anna M Eiring
Texas Tech University Health Sciences Center at El Paso
Co-authored papers
8
Anna Senina
Huntsman Cancer Institute, The University of Utah
Co-authored papers
7
Jamshid S Khorashad
Institute of Cancer Research
Co-authored papers
7
Hein Than
Singapore General Hospital
Co-authored papers
6
Jonathan M Ahmann
Huntsman Cancer Institute, The University of Utah
Co-authored papers
6
Brian J Druker
Oregon Health & Science University
Co-authored papers
5
Srinivas K Tantravahi
Huntsman Cancer Institute at the University of Utah.
Co-authored papers
5
Matthew S Zabriskie
University of Utah
Co-authored papers
5
Anca Franzini
University of Utah
Co-authored papers
4
Hannah M Redwine
Huntsman Cancer Institute, The University of Utah
Co-authored papers
3
Jeffrey W Tyner
Oregon Health & Science University School of Medicine
Co-authored papers
3
Christopher A Eide
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers
3
Amber D Bowler
Huntsman Cancer Institute, The University of Utah
Co-authored papers
2
Katherine E Varley
Huntsman Cancer Institute
Co-authored papers
2
Mark Yandell
University of Utah
Co-authored papers
1
Jae Y Hwang
The University of Utah
Co-authored papers
1
Kim-Hien T Dao
Astex Pharmaceuticals
Co-authored papers
1
Jason Gotlib
Stanford University School of Medicine
Co-authored papers
1
Anupriya Agarwal
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers
1
Dong Wook Kim
Yonsei University College of Medicine, Republic of Korea S. Biomedics Co.
Co-authored papers
1
Shannon K McWeeney
Oregon Health & Science University, University of California Berkeley
Co-authored papers
1
Julie A Reisz
University of Colorado Anschutz Medical Campus
Co-authored papers
1
Samantha L Savage
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers
1
Derek L Stirewalt
Fred Hutchinson Cancer Center
Co-authored papers
1
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Co-authored papers
1
Jerald P Radich
Fred Hutchinson Cancer Center
Co-authored papers
1
1 - 30